Literature DB >> 30046983

Pandemic Bacteremic Escherichia Coli Strains: Evolution and Emergence of Drug-Resistant Pathogens.

Yael Yair1, Uri Gophna2.   

Abstract

In recent years, there have been several pandemics of E. coli strains which are highly virulent and antibiotics resistant. Here, we discuss one recent pandemic strain, ST131. These E. coli strains are members of the virulence-associated phylogenetic group B2 and exhibit extraintestinal virulence factors, including various adhesins, toxins, siderophores, and protectins. This group often also harbors a diverse range of antimicrobial resistance types and mechanisms and may have particular metabolic capacities that enable it to colonize many individuals asymptomatically, while out competing other E. coli strains. Here, we discuss this clonal group in the context of other pathogenic E. coli and focus on its specific characteristics in terms of resistance, virulence, and metabolism.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30046983     DOI: 10.1007/82_2018_109

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  7 in total

1.  A Comprehensive Account of Escherichia coli Sequence Type 131 in Wastewater Reveals an Abundance of Fluoroquinolone-Resistant Clade A Strains.

Authors:  Thomas J Finn; Lena Scriver; Linh Lam; Mai Duong; Gisele Peirano; Tarah Lynch; Tao Dong; Johann D D Pitout; Rebekah DeVinney
Journal:  Appl Environ Microbiol       Date:  2020-02-03       Impact factor: 4.792

2.  Escherichia coli Bloodstream Infections in Patients at a University Hospital: Virulence Factors and Clinical Characteristics.

Authors:  Ana Paula Daga; Vanessa Lumi Koga; João Gabriel Material Soncini; Caroline Martins de Matos; Marcia Regina Eches Perugini; Marsileni Pelisson; Renata Katsuko T Kobayashi; Eliana Carolina Vespero
Journal:  Front Cell Infect Microbiol       Date:  2019-06-06       Impact factor: 5.293

3.  Antibiotic resistance, virulence, and phylogenetic analysis of Escherichia coli strains isolated from free-living birds in human habitats.

Authors:  Bartosz Rybak; Beata Krawczyk; Beata Furmanek-Blaszk; Magdalena Wysocka; Magdalena Fordon; Pawel Ziolkowski; Wlodzimierz Meissner; Katarzyna Stepniewska; Katarzyna Sikorska
Journal:  PLoS One       Date:  2022-01-12       Impact factor: 3.240

4.  Community Fecal Carriage and Molecular Epidemiology of Extended-Spectrum β-Lactamase- and Carbapenemase-Producing Escherichia coli from Healthy Children in the Central South China.

Authors:  Xuan Liu; Xin Li; A-Wen Yang; Bin Tang; Zi-Juan Jian; Yi-Ming Zhong; Hong-Ling Li; Yan-Ming Li; Qun Yan; Xiang-Hui Liang; Wen-En Liu
Journal:  Infect Drug Resist       Date:  2022-04-06       Impact factor: 4.003

5.  Effects of Artemisinin on Escherichia coli-Induced Mastitis in Bovine Mammary Epithelial Cells and Mice.

Authors:  Zhaoming Li; Jiaqing Hu; Xiaozhou Wang; Yongzhen Du; Jinhua Yin; Jian Gao; Bo Han; Shuai Cui; Yongxia Liu; Jianzhu Liu
Journal:  Vet Sci       Date:  2022-07-26

6.  Surviving Serum: the Escherichia coli iss Gene of Extraintestinal Pathogenic E. coli Is Required for the Synthesis of Group 4 Capsule.

Authors:  Dvora Biran; Thomas Sura; Andreas Otto; Yael Yair; Dörte Becher; Eliora Z Ron
Journal:  Infect Immun       Date:  2021-06-28       Impact factor: 3.441

7.  Control of Growth and Persistence of Listeria monocytogenes and β-Lactam-Resistant Escherichia coli by Thymol in Food Processing Settings.

Authors:  Maria Grazia Cusimano; Vita Di Stefano; Maria La Giglia; Vincenzo Di Marco Lo Presti; Domenico Schillaci; Francesco Pomilio; Maria Vitale
Journal:  Molecules       Date:  2020-01-17       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.